Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01593605 · ClinicalTrials.gov registry record · NA
Resveratrol-Leucine Metabolite Synergy in Pre-diabetes
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT01593605 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 36 participants.
The verdict
NCT01593605, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The study will evaluate the effects of resveratrol/leucine and resveratrol/HMB for their ability to control glucose levels in persons without diabetes but with impaired fasting glucose. Secondary assessments will examine the effect of these nutritional supplements versus placebo on inflammation, fasting lipids, HbA1C, and fructosamine, longer term metabolic markers of risk in diabetes.
Interventions
- OTHER Placebo treatment
- DIETARY_SUPPLEMENT Resveratrol
- DIETARY_SUPPLEMENT resveratrol /HMB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2012-02 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01593605
The ClinicalTrials.gov registry entry for NCT01593605 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo treatment is the first listed.
NCT01593605 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01593605 about?
NCT01593605 is a clinical study titled "Resveratrol-Leucine Metabolite Synergy in Pre-diabetes". The study will evaluate the effects of resveratrol/leucine and resveratrol/HMB for their ability to control glucose levels in persons without diabetes but with impaired fasting glucose. Secondary assessments will examine the effect of these nutritional supplements versus placebo on inflammation, fas...
What is the current status of trial NCT01593605?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2012-02. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01593605?
The interventions under investigation include: Placebo treatment (OTHER), Resveratrol (DIETARY_SUPPLEMENT), resveratrol /HMB (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01593605?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.